These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 21106544

  • 21. Dobutamine-induced improvement in inferior myocardial contractile function predicts reduction in functional mitral regurgitation: a study using tissue Doppler strain rate imaging.
    Tatsumi K, Kawai H, Sugiyama D, Norisada K, Kataoka T, Onishi T, Tanaka H, Hirata K.
    Circ Cardiovasc Imaging; 2010 Nov; 3(6):638-46. PubMed ID: 20826593
    [Abstract] [Full Text] [Related]

  • 22. Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy.
    Pocar M, Di Mauro A, Passolunghi D, Moneta A, Alsheraei AM, Bregasi A, Mattioli R, Donatelli F.
    Eur J Cardiothorac Surg; 2010 May; 37(5):1093-100. PubMed ID: 20060737
    [Abstract] [Full Text] [Related]

  • 23. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K, Karaahmet T, Tanalp AC, Gurel E, Cevik C, Mutlu B, Basaran Y.
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [Abstract] [Full Text] [Related]

  • 24. Intraventricular and papillary muscle dyssynchrony is related to the diastolic phase of functional mitral regurgitation in patients with non-ischemic dilated cardiomyopathy.
    Karaahmet T, Tigen K, Dundar C, Cevik C, Guler A, Gurel E, Kirma C.
    J Heart Valve Dis; 2011 Mar; 20(2):136-45. PubMed ID: 21560811
    [Abstract] [Full Text] [Related]

  • 25. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study.
    Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ.
    Circulation; 2000 Sep 19; 102(12):1400-6. PubMed ID: 10993859
    [Abstract] [Full Text] [Related]

  • 26. Grading functional mitral regurgitation by tissue Doppler-derived isovolumic acceleration parameters in patients with nonischemic dilated cardiomyopathy.
    Karaahmet T, Tigen K, Gurel E, Cevik C, Dundar C, Fotbolcu H, Pala S, Basaran Y.
    Echocardiography; 2010 Aug 19; 27(7):815-22. PubMed ID: 20546008
    [Abstract] [Full Text] [Related]

  • 27. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure.
    Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A, Stellbrink C.
    J Am Coll Cardiol; 2003 Mar 05; 41(5):765-70. PubMed ID: 12628720
    [Abstract] [Full Text] [Related]

  • 28. Predicting clinical outcome by indexed mitral valve tenting in functional mitral valve regurgitation.
    von Stumm M, Dudde F, Holst T, Sequeira-Gross T, Pausch J, Müller L, Sinning CR, Reichenspurner H, Girdauskas E.
    Open Heart; 2021 Jan 05; 8(1):. PubMed ID: 33495382
    [Abstract] [Full Text] [Related]

  • 29. Echocardiographic determinants of ischemic mitral regurgitation.
    Nouri M, Tokaldany ML, Shahrzad M, Mardanloo AS, Ahmadi SH, Roomi ZS, Sadeghian H.
    J Card Surg; 2013 Jul 05; 28(4):359-65. PubMed ID: 23879338
    [Abstract] [Full Text] [Related]

  • 30. Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
    Konstantinou DM, Papadopoulou K, Giannakoulas G, Kamperidis V, Dalamanga EG, Damvopoulou E, Parcharidou DG, Karamitsos TD, Karvounis HI.
    Echocardiography; 2014 Jul 05; 31(1):21-8. PubMed ID: 23930844
    [Abstract] [Full Text] [Related]

  • 31. The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy.
    Tigen K, Karaahmet T, Kirma C, Kilicgedik A, Dundar C, Pala S, Cevik C, Guler A, Gurel E, Basaran Y.
    Cardiol J; 2010 Jul 05; 17(3):274-80. PubMed ID: 20535718
    [Abstract] [Full Text] [Related]

  • 32. The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy.
    Nagasaki M, Nishimura S, Ohtaki E, Kasegawa H, Matsumura T, Nagayama M, Koyanagi T, Tohbaru T, Misu K, Asano R, Sumiyoshi T, Hosoda S.
    Int J Cardiol; 2006 Apr 04; 108(2):171-6. PubMed ID: 15916824
    [Abstract] [Full Text] [Related]

  • 33. Incremental value of global systolic dyssynchrony in determining the occurrence of functional mitral regurgitation in patients with left ventricular systolic dysfunction.
    Liang YJ, Zhang Q, Fang F, Lee AP, Liu M, Yan BP, Lam YY, Chan GC, Yu CM.
    Eur Heart J; 2013 Mar 04; 34(10):767-74. PubMed ID: 22613344
    [Abstract] [Full Text] [Related]

  • 34. Interpapillary muscle distance independently affects severity of functional mitral regurgitation in patients with systolic left ventricular dysfunction.
    Kim K, Kaji S, An Y, Nishino T, Tani T, Kitai T, Furukawa Y.
    J Thorac Cardiovasc Surg; 2014 Aug 04; 148(2):434-40.e1. PubMed ID: 24189316
    [Abstract] [Full Text] [Related]

  • 35. Functional mitral regurgitation predicts prognosis independent of left ventricular systolic and diastolic indices in patients with ischemic heart disease.
    Okura H, Takada Y, Kubo T, Asawa K, Taguchi H, Toda I, Yoshiyama M, Yoshikawa J, Yoshida K.
    J Am Soc Echocardiogr; 2008 Apr 04; 21(4):355-60. PubMed ID: 17658723
    [Abstract] [Full Text] [Related]

  • 36. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL, Fontanive P, Conti U, Andreini D, Cabani E, De Tommasi SM.
    Am Heart J; 2008 Jun 04; 155(6):1121-7. PubMed ID: 18513528
    [Abstract] [Full Text] [Related]

  • 37. Elevated uric acid and functional mitral regurgitation in dilated cardiomyopathy.
    Yazicioğlu MV, Avci A, Açar G, Esen Ö, Karaca O, Alici G, Özkan B, Alizade E, Bulut M, Akçakoyun M, Esen AM.
    Eur Rev Med Pharmacol Sci; 2012 Nov 04; 16(12):1637-41. PubMed ID: 23161034
    [Abstract] [Full Text] [Related]

  • 38. The role of B-type natriuretic peptide in the evaluation of left atrioventricular valve regurgitation following surgical repair of partial atrioventricular canal.
    Wójcik A, Klisiewicz A, Szymański P, Janas J, Różański J, Kuśmierczyk M, Hoffman P.
    Kardiol Pol; 2012 Nov 04; 70(5):464-70. PubMed ID: 22623236
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.